Global Clinical Pharmacology
Joint venture between Hospital Corp. of America and the Institute of Clinical Pharmacology established to manage clinical research using HCA hospitals. ICP will own 80% of the joint venture and contribute its worldwide medical research operations. Global, headquartered in Nashville on the HCA campus, will be headed by ICP Chairman and CEO Austin Darragh. HCA is putting up $2.6 mil. for its 20% stake.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.